Capstone Therapeutics Corp. (CAPS) vs Smith-Midland Corp. (SMID)
Capstone Therapeutics Corp. and Smith-Midland Corp. are both Building Materials companies. Smith-Midland Corp. is the larger, with a market value of $127.4M against $3.7M — 34.5× the size. Capstone Therapeutics Corp. has negative trailing earnings, so its P/E is not meaningful; Smith-Midland Corp. trades at 16.7×. Capstone Therapeutics Corp. grew revenue faster over the last twelve months: 38.9% against −1.65%. Smith-Midland Corp. has the higher net margin (8.63% vs −36.7%) and the higher return on invested capital (13.5% vs −17.2%). Across the 18 metrics below, Smith-Midland Corp. leads on 11 and Capstone Therapeutics Corp. on 7.
Valuation
Profitability
| Metric | CAPS | SMID | Building Materials median |
|---|---|---|---|
| Gross margin | 25.40% | 23.46% | 27.27% |
| Operating margin | (17.20%) | 12.07% | 13.85% |
| Net margin | (36.68%) | 8.63% | 9.59% |
| Free cash flow margin | (6.33%) | 4.68% | 8.06% |
| Return on equity | (114.39%) | 14.54% | 9.62% |
| Return on assets | (41.47%) | 9.21% | 5.86% |
| Return on invested capital | (17.20%) | 13.54% | 6.03% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack